{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:33:12Z","timestamp":1776119592304,"version":"3.50.1"},"reference-count":10,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,4,6]]},"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1183\/13993003.00388-2022","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T08:31:00Z","timestamp":1652949060000},"page":"2200388","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Rifapentine access in Europe: growing concerns over key tuberculosis treatment component"],"prefix":"10.1183","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-9635","authenticated-orcid":false,"given":"Lorenzo","family":"Guglielmetti","sequence":"first","affiliation":[]},{"given":"Gunar","family":"G\u00fcnther","sequence":"additional","affiliation":[]},{"given":"Claude","family":"Leu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-1535","authenticated-orcid":false,"given":"Daniela","family":"Cirillo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-3099","authenticated-orcid":false,"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Alberto L.","family":"Garcia-Basteiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-4376","authenticated-orcid":false,"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0171-764X","authenticated-orcid":false,"given":"Mateja","family":"Jankovic","sequence":"additional","affiliation":[]},{"given":"Liga","family":"Kuksa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-5964","authenticated-orcid":false,"given":"Florian P.","family":"Maurer","sequence":"additional","affiliation":[]},{"given":"Fr\u00e9d\u00e9ric","family":"M\u00e9cha\u00ef","sequence":"additional","affiliation":[]},{"given":"Simon","family":"Tiberi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5490-8968","authenticated-orcid":false,"given":"Frank","family":"van Leth","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-6544","authenticated-orcid":false,"given":"Nicolas","family":"Veziris","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-4741","authenticated-orcid":false,"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"2024102006401918000_59.5.2200388.1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5588\/ijtld.21.0736","article-title":"The need for effective drugs for TB prevention: set your goals high, and don't stop till you get there","volume":"26","author":"Lange","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102006401918000_59.5.2200388.2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-rifapentine for latent tuberculosis infection: a systematic review and meta-analysis","volume":"55","author":"Njie","year":"2018","journal-title":"Am J Prev Med"},{"key":"2024102006401918000_59.5.2200388.3","doi-asserted-by":"crossref","unstructured":"World Health Organization . WHO Consolidated Guidelines on Tuberculosis. Module 1: Prevention \u2013 Tuberculosis Preventive Treatment. Geneva, World Health Organization, 2020.","DOI":"10.30978\/TB2021-2-86"},{"key":"2024102006401918000_59.5.2200388.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806808"},{"key":"2024102006401918000_59.5.2200388.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033400"},{"key":"2024102006401918000_59.5.2200388.6","unstructured":"World Health Organization . Treatment of Drug-susceptible Tuberculosis: Rapid Communication. Geneva, World Health Organization, 2021."},{"key":"2024102006401918000_59.5.2200388.7","unstructured":"Treatment Action Group. An Activist's Guide to Rifapentine for the Treatment of TB Infection. Updated April 2020. Date last accessed: 12 May 2021. www.treatmentactiongroup.org\/publication\/an-activists-guide-to-rifapentine-for-the-treatment-of-tb-infection\/"},{"key":"2024102006401918000_59.5.2200388.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02089-2018"},{"key":"2024102006401918000_59.5.2200388.9","doi-asserted-by":"crossref","unstructured":"G\u00fcnther G , Guglielmetti L , Leu C , et al. Cost and availability of drugs and treatment regimens and availability of drug resistance testing for tuberculosis in Europe. medRxiv 2022; preprint [https:\/\/doi.org\/10.1101\/2022.02.15.22271006].","DOI":"10.1101\/2022.02.15.22271006"},{"key":"2024102006401918000_59.5.2200388.10","unstructured":"de Vries G . Importance of Rifapentine (Priftin\u00ae) for TB Elimination in Europe. Date last updated: 7 June 2016. Date last accessed: 17 May 2021. www.kncvtbc.org\/uploaded\/2017\/02\/Letter-to-Sanofi-re-Rifapentine-in-Europe.pdf"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00388-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:07:24Z","timestamp":1740380844000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00388-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,19]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1183\/13993003.00388-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00388-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}